IBM (NYSE: IBM) director defers board fees into 377 share award

Rhea-AI Filing Summary

INTERNATIONAL BUSINESS MACHINES CORP director Thomas Buberl received a compensation-related equity grant. On this Form 4, he acquired 377 Promised Fee Shares tied to IBM common stock at a reference price of $242.39 per share through the IBM Board of Directors Deferred Compensation and Equity Award Plan.

These Promised Fee Shares represent deferred board fees, with distribution in IBM common stock or cash after retirement under the plan. Following this award, Buberl holds 14,278 shares of IBM common stock directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Buberl Thomas

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Promised Fee Share	377	$242.39	$91K

Holdings After Transaction: Promised Fee Share — 14,278 shares (Direct)

Footnotes (1)

1. Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash. Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan. Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement.

Key Figures

Promised Fee Shares granted: 377 shares Reference price per share: $242.39 per share Shares held after transaction: 14,278 shares

3 metrics

Promised Fee Shares granted 377 shares Deferred director fees under IBM Board of Directors Deferred Compensation and Equity Award Plan

Reference price per share $242.39 per share Valuation used for the 377 Promised Fee Shares grant

Shares held after transaction 14,278 shares IBM common stock directly owned by Thomas Buberl following the award

Key Terms

Promised Fee Shares, Deferred Compensation and Equity Award Plan, deferral of fees

3 terms

Promised Fee Shares financial

"Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement"

Deferred Compensation and Equity Award Plan financial

"under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement"

deferral of fees financial

"Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Buberl Thomas

(Last) (First) (Middle)

C/O SECRETARY'S OFFICE, IBM CORPORATION

ONE NEW ORCHARD ROAD

(Street)

ARMONK NEW YORK 10504

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INTERNATIONAL BUSINESS MACHINES CORP [ IBM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Promised Fee Share	$0.00(1)	03/31/2026		A(2)		377		(3)	(3)	Common Stock	377	$242.39	14,278	D

Explanation of Responses:

1. Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan are paid out after retirement in the company's common stock or cash.

2. Deferral of fees into Promised Fee Shares under the terms of the IBM Board of Directors Deferred Compensation and Equity Award Plan.

3. Distribution of Promised Fee Shares under the IBM Board of Directors Deferred Compensation and Equity Award Plan is deferred until retirement.

Remarks:

	L. Mallardi on behalf of T. Buberl	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did IBM director Thomas Buberl report on this Form 4 for IBM?

Thomas Buberl reported an acquisition of 377 Promised Fee Shares linked to IBM common stock. The award reflects deferred board fees under IBM’s Board of Directors Deferred Compensation and Equity Award Plan, rather than an open-market stock purchase.

Is the IBM (IBM) Form 4 transaction a market buy or a compensation grant?

The transaction is a compensation-related grant, not a market buy. Buberl received 377 Promised Fee Shares as a deferral of director fees under IBM’s Board of Directors Deferred Compensation and Equity Award Plan, with payout after retirement.

How many IBM shares does Thomas Buberl hold after this reported Form 4 transaction?

After this transaction, Thomas Buberl holds 14,278 IBM common shares directly. The filing shows his position after receiving 377 Promised Fee Shares, which are scheduled for distribution in stock or cash when he retires from IBM’s board.

What are Promised Fee Shares in IBM’s director compensation plan?

Promised Fee Shares are deferred director fees credited as share units under IBM’s Board of Directors Deferred Compensation and Equity Award Plan. They are ultimately paid out in IBM common stock or cash, with distribution deferred until the director’s retirement from the board.

At what price were the IBM Promised Fee Shares valued in this Form 4 filing?

The 377 Promised Fee Shares were valued at $242.39 per share in the Form 4. This price serves as a reference for the deferred fee share award, not an execution price from an open-market stock trade by the director.